During the past decade, LLC "RIAT SPb" conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "LLC "RIAT SPb"" are "Colitis, Ulcerative" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "LLC "RIAT SPb"" in a lesser frequency.

Most popular intervention types in "LLC "RIAT SPb"" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Placebo IV" (1 trials), "Placebo SC" (1 trials), "Vedolizumab 108 mg SC" (1 trials) and "Vedolizumab 300 mg IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "LLC "RIAT SPb"" are 3 trials for "All" genders.

Currently, there are NaN active trials in "LLC "RIAT SPb"". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in LLC "RIAT SPb", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LLC "RIAT SPb", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".